ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,995,000 | +60.2% | 636,013 | 0.0% | 4.51% | +60.3% |
| Q2 2019 | $7,486,000 | -4.0% | 636,013 | +11.4% | 2.81% | -16.3% |
| Q1 2019 | $7,794,000 | +92.0% | 571,013 | +44.2% | 3.36% | +66.6% |
| Q4 2018 | $4,059,000 | -38.4% | 396,013 | 0.0% | 2.02% | -25.5% |
| Q3 2018 | $6,594,000 | +5.4% | 396,013 | 0.0% | 2.71% | -7.6% |
| Q2 2018 | $6,257,000 | +24.4% | 396,013 | 0.0% | 2.93% | +19.7% |
| Q1 2018 | $5,029,000 | +26.9% | 396,013 | +14.5% | 2.45% | +14.7% |
| Q4 2017 | $3,962,000 | -6.5% | 346,013 | 0.0% | 2.13% | -18.9% |
| Q3 2017 | $4,239,000 | +67.5% | 346,013 | +56.6% | 2.63% | +45.7% |
| Q2 2017 | $2,531,000 | -44.9% | 221,013 | 0.0% | 1.81% | -53.5% |
| Q1 2017 | $4,597,000 | 0.0% | 221,013 | 0.0% | 3.89% | -3.7% |
| Q4 2016 | $4,597,000 | -15.1% | 221,013 | +33.7% | 4.04% | +7.1% |
| Q3 2016 | $5,417,000 | +31.2% | 165,313 | 0.0% | 3.77% | +15.3% |
| Q2 2016 | $4,128,000 | +20.1% | 165,313 | +17.8% | 3.27% | +10.4% |
| Q1 2016 | $3,436,000 | +477.5% | 140,313 | +679.5% | 2.96% | +459.2% |
| Q4 2015 | $595,000 | +0.8% | 18,000 | 0.0% | 0.53% | -9.4% |
| Q3 2015 | $590,000 | – | 18,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |